業績

2021年 研究・実績

英論文

Ⅰ.著書（単行本・分担執筆）
Ⅱ.原著・総説
  1. Komatsu M, Yamamoto H, Kitaguchi Y, Kawakami S, Matsushita M, Uehara T, Kinjo T, Wada Y, Ichiyama T, Urushihata K, Ushiki A, Yasuo M, Hanaoka M. Clinical characteristics of non-idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung diseases：A Single-center retrospective study. Medicine.2021；100（issue13）:e25322
    doi:10.1097/MD.0000000000025322
  2. Nozawa S, Urushihata K, Machida R, Hanaoka M. The risk assessment by clinical background and cephalometry for obstructive sleep apnea with CPAP indication in Japanese. Sleep and Biological Rhythms.
    2021；19:145–154
    doi:org/10.1007/s41105-020-00301-w
  3. Koizumi T, Kanda S, Nihonmatu R, Gomi D, Sekiguchi N, Noguchi T, Fukushima T, Kobayashi T, Yamamoto H, Takeda T. Primary mediastinal germ cell tumors- A retrospective analysis of >30 years of experience in a single institution. Thoracic Cancer. 2021；12（issue6）：807-813　doi:10.1111/1759-7714.13859
  4. Kawabata H, Fujimoto S, Sakai T, Yanagisawa H, Kitawaki T, Nara K, Hagihara M, Yamamoto H. Patient’s age and d-dimer levels predict the prognosis in patients with TAFRO syndrome. International Journal of Hematology.2021；114：179-188　doi:10.1007/s12185-021-03159-x
  5. Nishie K, Yamamoto S, Yamaga T, Horita N, Mori R, Gouda MA, Hanaoka M. Prophylactic cranial irradiation for extensive-stage small cell lung cancer (Protocol). Cochrane Database of Systematic Reviews 2021；Issue 3. Art. No.: CD014559.
    doi: 10.1002/14651858.CD014559
  6. Urushihata K, Yunden Droma, Ito M, Hanaoka M. Hypoxic Ventilatory Response to Acute and Prolonged Hypoxic Exposures in Subjects Susceptible to High-altitude Pulmonary Edema. Shinshu Medical journal. 2021；69（4）：179-187
    https://doi.org/10.11441/shinshumedj.69.179
  7. Sonehara K, Tateishi K, Araki T, Komatsu M, Yamamoto H, Koizumi T, Hanaoka M. The Role of Immune-Related Adverse Events in Prognosis and Efficacy Prediction for Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: A Retrospective Clinical Analysis. Oncology. 2021；99：271-279　doi:10.1159/000511999
  8. Sonehara K, Tateishi K, Araki T, Komatsu M, Yamamoto H, Hanaoka M. Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non-small cell lung cancer who subsequently underwent immunotherapy. Thorac Cancer. 2021；12（9）：1366-1372　doi:10.1111/1759-7714.13909
  9. Kinugawa Y, Uehara T, Iwaya M, Asaka S, Kobayashi S, Nakajima T, Komatsu M, Yasuo M, Yamamoto H, Ota H. IL-6 expression helps distinguish Castleman’s disease from IgG4-related disease in the lung. BMC Pulm Med. 2021 Jul 10；21：219
    doi: 10.1186/s12890-021-01603-6.
  10. Akahane J, Ushiki A, Kosaka M, Ikuyama Y, Matsuo A, Hachiya T, Yoshiike F, Koyama S, Hanaoka M. Blood urea nitrogen-to-serum albumin ratio and A-DROP are useful in assessing the severity of Pneumocystis pneumonia in patients without human immunodeficiency virus infection. Journal of Infection and Chemotherapy. 2021；27：707-714
    doi:10.1016/j.jiac.2020.12.017
  11. Komatsu M, Yamamoto H, Matsui S, Terasaki Y, Hebisawa A, Iwasawa T, Johkoh T, Baba T, Miyamoto A, Handa T, Tomii K, Waseda Y, Bando M, Ishii H, Miyazaki Y, Oshizawa A, Takemura T, Kawabata Y, Ogura T. Clinical characteristics of immunoglobulin G4-positive interstitial pneumonia. ERJ Open Reserch.2021; 7：00317-2021
    doi:10.1183/23120541.00317-2021
  12. Nozawa S, Urushihata K, Machida R, Hanaoka M. The positional characteristics of patients with obstructive sleep apnea:a single institute retrospective study in Japan. Sleep and Biological Rhythms.2021.
    doi:10.1007/s41105-021-00347-4
  13. Morichika D, Taniguchi A, Oda N, Fujii U, Senoo S, Itano J, Kanehiro　 A, Kitaguchi Y, Yasuo M, Hanaoka M, Satoh T, Akira S, Kiura K, Maeda Y, Miyahara N. Loss of IL-33 enhances elastase-induced and cigarette smoke extract-induced emphysema in mice. Respiratory Research. 2021；22(1):150.　doi:10.1186/s12931-021-01705-z
  14. Araki T, Yamazaki Y, Goto N, Takahashi Y, Ikuyama Y, Kosaka M.Prognostic value of geriatric nutritional risk index for aspiration pneumonia: a retrospective observational cohort study. Aging Clinical and Experimental Research. 2021　doi:10.1007/s40520-021-01948-2
  15. Araki T, Tateishi K, Sonehara K, Hirota S, Komatsu M, Yamamoto M, Kanda S, Kuraishi H, Hanaoka M, Koizumi T. Clinical utility of the C-reactive protein:albumin ratio in non-small cell lung cancer patients treated with nivolumab. Thoracic Cancer. 2021；12（Issue5）：603-612
    doi:10.1111/1759-7714.13788
  16. Kawabata H, Fujimoto S, Sakai T, Yanagisawa H, Kitawaki T, Nara K, Hagihara M, Yamamoto H, Tanimizu M, Kato C, Origuchi T, Sunami K, Sunami Y, Masunari T, Nakamura N, Kobayashi M, Yamagami K, Miura K, Takai K, Aoki S, Tsukamoto N, Masaki Y. Correction to: Patient’s age and D‑dimer levels predict the prognosis in patients with TAFRO syndrome. International Journal of Hematology. 2021；114：301-302
    doi:10.1007/s12185-021-03170-2
  17. Kitaguchi Y, Fujimoto K, Droma Y, Yasuo M, Wada Y, Ueno F, Kinjo T, Kawakami S, Fukushima K, Hanaoka M. Automated Diseased Lung Volume Percentage Calculation in Quantitative CT Evaluation of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. Journal of Computer Assisted Tomography.2021；45：649-658.
    doi: 10.1097/RCT.0000000000001182.
  18. Araki T, Kitaguchi Y, Suzuki Y, Komatsu M, Sonehara K, Wada Y, Tateishi K, Hanaoka M. Prognostic implication of erector spinae muscles in non-small-cell lung cancer patients treated with immuno-oncology combinatorial chemotherapy. Thoracic Cancer.2021.12：2857-2864
    doi: 10.1111/1759-7714.14142.
  19. Goto N, Wada Y, Ikuyama Y, Akahane J, Kosaka M, Ushiki A, Kitaguchi Y, Yasuo M, Yamamoto H, Matsuo A, Hachiya T, Ideura G, Yamazaki Y, Hanaoka M. The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019. Journal of Infection and Chemotherapy.2021. 27(12):1706-1712
    doi: 10.1016/j.jiac.2021.08.009
Ⅲ.症例報告
  1. Nishina S, Sakai H, Kawakami T, Kanai S, Ushiki A, Natori T, Igarashi Y, Mitarai S, Yoshiyama T, Ishida F, Nakazawa H. Isolated splenic Mycobacterium tuberculosis complex infection in an immunocompetent individual with FDG-PET positive mass. Journal of infection and Chemotherapy. 2021；27：354-358.　 https://doi.org/10.1016/j.jiac.2020.09.018
  2. Sonehara K, Tateishi K, Hirabayashi T, Araki T, Ikuyama Y, Machida R, Hanaoka M. A Case of Lung Adenocarcinoma with Long-Term Response after Late-Onset Pembrolizumab-Induced Acute Adrenal Insufficiency. Case Reports in Oncology. 2021；14：1-7　doi: 10.1159/000508068
  3. Araki T, Kobayashi T, Kobayashi S, Sonehara K, Tateishi K, Kanda S, Hanaoka M, Koizumi T. Thymic epithelial tumor with superior vena cava syndrome diagnosed by percutaneous endovascular tumor biopsy: A report of two cases. Respiratory Investigation. 2021；59（Issue5）：695-699　doi:10.1016/j.resinv.2021.04.003
  4. Sonehara K, Araki T, Hanaoka M. Rothia aeria pneumonia in an immunocompetent patient: A novel case study. Respirology Case Reports. 2021；9：e0843　doi:10.1002/rcr2.843
  5. Sonehara K, Tateishi K, Araki T, Komatsu M, Akahane J, Yamamoto H, Hanaoka M. Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series. Case Reports in Oncology. 2021；14：1561-1566
    doi:10.1159/000519597

和論文

Ⅰ.著書（単行本・分担執筆）
  1. 花岡正幸.5呼吸器疾患「呼吸器疾患　最近の動向」.福井次矢・高木　誠・小室一成 総編.TODAY’S THERAPY2021今日の治療指針 私はこう治療している.Volume63.pp272-275.㈱医学書院.東京.2021（2021.1.1発行）
  2. 花岡正幸.Ⅲ呼吸器系の救急治療「10.高地肺水腫」.門田淳一・弦間昭彦・西岡安彦 編.呼吸器疾患最新の治療2021-2022.第1版.pp174-176. ㈱南江堂.東京.2021（2021.3.1発行）
  3. 花岡正幸.Ⅸ医原性肺疾患「1.薬剤性肺障害」.門田淳一・弦間昭彦・西岡安彦 編.呼吸器疾患最新の治療2021-2022.第1版.pp333-335. ㈱南江堂.東京.2021（2021.3.1発行）
  4. 花岡正幸.特集 呼吸器疾患ガイドライン（改訂／発刊）がもたらしたものと、次回改定に向けた課題「薬剤性肺障害の診断・治療の手引き第2版」.呼吸器内科編集委員会 編.Respiratory Medicine 呼吸器内科.Vol.39 No.5.pp404-409. 科学評論社.東京.2021（2021.5.8発行）
  5. 花岡正幸.呼吸機能検査ハンドブック.第1版.一般社団法人日本呼吸器学会.東京.2021（2021.7.20発行）
  6. 花岡正幸.肺循環の異常　高地肺水腫.長谷川好規. 呼吸器症候群.第3版.Ⅴ－２－（４）228頁～231頁.株式会社日本臨牀社.東京.2021
Ⅱ.論文原著・総説
Ⅲ.症例報告
Ⅳ.その他
Ⅴ.受賞

内科学第一教室の紹介

< 戻る